Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

A deep learning radiomic biomarker has been developed and validated to predict responses to immune checkpoint inhibitors in ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical ...

Lung cancer researcher, Bryant Kin, has been diagnosed with the disease despite never smoking himself in his life, he's ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

George Barlow, a former smoker who was diagnosed with non-small cell lung cancer, learned that he had the disease after undergoing a low-dose CT scan last year. "I would’ve never known that I ...

Lung cancer is the third most common cancer and the leading cause of cancer-related deaths in the U.S., and according to the ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...